Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Intercept Pharma
Intercept Pharma
FDA Warns Doctors After 19 Deaths on Intercept Liver Drug
Bloomberg
Fri, 09/22/17 - 09:16 am
FDA
Intercept Pharma
Ocaliva
liver disease
Intercept cuts targets for pivotal NASH study
BioPharma Dive
Tue, 02/14/17 - 09:37 am
Intercept Pharma
NASH
clinical trials
OCA
obeticholic acid
3 Biotechs Likely to Be Acquired in 2017
Motley Fool
Mon, 01/23/17 - 10:18 am
M&A
Clovis Oncology
Intercept Pharma
Jazz Pharmaceuticals
3 Potential Acquisition Targets for Gilead Sciences, Inc.
Motley Fool
Wed, 11/16/16 - 10:00 pm
Gilead Sciences
Kite Pharma
Tesaro
Intercept Pharma
M&A
Pfizer's Medivation buy seen prescribing more biotech M&A
Yahoo/Reuters
Mon, 08/22/16 - 10:30 pm
Pfizer
Medivation
M&A
biotech
Vertex Pharmaceuticals
Alexion
Neurocrine
Intercept Pharma
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
Intercept Wins FDA Approval for Drug to Treat Liver Disease
Bloomberg
Mon, 05/30/16 - 10:08 am
Intercept Pharma
FDA
Ocaliva
obeticholic acid
primary biliary cirrhosis
2 Hotly Debated Drugs Due For FDA Decisions Next Week
Investors.com
Sat, 05/21/16 - 12:35 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Intercept Pharma
Ocaliva
liver disease
primary biliary cholangitis
3 Biotech Stocks Buoyed By Potential Blockbuster Drugs
Investors.com
Sat, 05/7/16 - 01:13 pm
JCAR015
Juno Therapeutics
Kyndrisa
Biomarin
Intercept Pharma
Ocaliva
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Humira
Amgen
Bristol-Myers Squibb
Coherus Biosciences
Gilead Sciences
Intercept Pharma
JNJ
Novartis
Pfizer
FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease
Fierce Biotech
Thu, 04/7/16 - 09:40 pm
FDA
advisory panels
Intercept Pharma
OCA
primary biliary cirrhosis
Who Is Gilead Going To Buy?
Seeking Alpha
Mon, 03/7/16 - 10:07 pm
Gilead Sciences
M&A
Genfit
Intercept Pharma
Agios Pharmaceuticals
Ziopharm
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Sat, 02/13/16 - 09:25 am
FDA
Acadia
Intercept Pharma
Clovis Oncology
Nuplazid
OCA
rociletinib
Intercept books a date with the FDA as buyout rumors simmer
Fierce Biotech
Thu, 02/11/16 - 09:03 pm
Intercept Pharma
FDA
M&A
1 Company Gilead Sciences Should Consider Buying Right Now
Motley Fool
Sat, 02/6/16 - 12:28 pm
Gilead Sciences
M&A
hepatitis C
Intercept Pharma
Blockbuster new launches coming from Intercept, Gilead and Merck: Reuters
Fierce Pharma
Fri, 02/5/16 - 09:51 am
drug launches
Intercept Pharma
Gilead Sciences
Merck
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
Yahoo
Mon, 08/31/15 - 08:26 am
FDA
Intercept Pharma
obeticholic acid
priority review
primary biliary cirrhosis
Will This Drug Beat Gilead to Market in NASH?
Investopedia
Sat, 05/23/15 - 11:35 am
Gilead Sciences
NASH
OCA
Intercept Pharma
Intercept reports 1Q loss
Yahoo/AP
Mon, 05/11/15 - 08:38 am
Intercept Pharma
earnings
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »